Search
for
Sort by
Research 571–600 of 1000+
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- Sp6 downregulation of follistatin gene expression in ameloblasts
- The eyelash follicle features and anomalies: A review
- How to Diagnose Hair Loss
- Artificial skin for wound healing
- Isolation and Characterization of a Novel Hair Follicle–Specific Gene, Hacl-1
- Female patients complaining about hair loss: documentation of defective scalp hair dynamics with contrast-enhanced phototrichogram
- Novedades terapéuticas en tricología
- Liposuction and Tumescent Surgery
- HAIR MATRIX CELL KINETICS: A SELECTIVE REVIEW
- Skin manifestations of chronic kidney disease
- Syphilitic Alopecia: A Report of 5 Cases and a Review of the Literature
- Natural hair patterns
- Design of an artificial skin. IV. Use of island graft to isolate organ regeneration from scar synthesis and other processes leading to skin wound closure
- Comparative biology of tissue repair, regeneration and aging
- Estudio transversal acerca de los hábitos de prescripción en alopecia androgénica de los dermatólogos en España en 2017
- Epidermal growth factor, innovation and safety
- Is Baldness Bad for the Heart?
- Uso de la espironolactona en dermatología: acné, hidradenitis supurativa, alopecia femenina e hirsutismo
- Novel therapies for alopecia areata: The era of rational drug development
- Histopathological investigation of clinically non‐affected perilesional scalp in alopecias detected unexpected spread of disease activities
- Reply to: “Updated diagnostic criteria for frontal fibrosing alopecia”
- New Treatments for Hair Loss
- Tinea Capitis: Trends in Spain
- Removal of Intact Hair Papilla and Connective Tissue Sheath by Plucking Anagen Hairs**From the Department of Dermatology of the University of Hamburg, Germany.
- Function and interactions of the Ysc84/SH3yl1 family of actin- and lipid-binding proteins
- Pinnal Diseases
- Rituximab for Bone Lymphoma
- TREMendous Macrophages Inhibit Hair Growth
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm